Phaim Pharma
PrivateLast Round
Convertible Debt
Apr 1, 2021
Company Overview
Phaim Pharma operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Convertible Debt round in April 2021.
Phaim Pharma is a biotechnology company that develops curative treatments and diagnostic tools for autoimmune diseases, with a primary focus on Type 1 Diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phaim Pharma Comparables
Compare Phaim Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imcyse | 87% | |
| Ahead Therapeutics | 84% | |
| IM Therapeutics | 84% |
For institutional investors. Book with your work email.
Phaim Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Apr 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Phaim Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| British Business Bank | Convertible Debt |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Monthly visitors grew 45% MoM, from 901 to 1.3K.
- Apr 1, 2021
British Business Bank participated in the round.
For institutional investors. Book with your work email.
Phaim Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Phaim Pharma's valuation, stock price, and market status.
Is Phaim Pharma a public or private company?
Phaim Pharma is a private company.
What is the current stock price of Phaim Pharma?
Phaim Pharma is a private company, so its shares have no public market price. Caplight tracks Phaim Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phaim Pharma worth (valuation)?
Valuation information for Phaim Pharma is not publicly available.
Can I buy Phaim Pharma stock?
Phaim Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phaim Pharma's last funding round?
Phaim Pharma's most recent funding round was Convertible Debt on April 1, 2021.
Who are the main investors in Phaim Pharma?
Key investors in Phaim Pharma include British Business Bank, Innovate UK.
Will Phaim Pharma IPO soon?
No public IPO plans have been announced for Phaim Pharma.
How can I track Phaim Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Phaim Pharma's shares on secondary markets.